St. Jude Children’s Research Hospital is temporarily relocating 500 employees from working on the hospital’s campus to office space at 150 Peabody Place in downtown Memphis.
St. Jude Children’s Research Hospital is temporarily relocating 500 employees from working on the hospital’s campus to office space at 150 Peabody Place in downtown Memphis. The move, which will begin in April, provides additional administrative space while St. Jude expands operations, constructs new facilities, completes renovations and hires more faculty and staff, as outlined in its 2022–2027 strategic plan.
The hospital is leasing space previously occupied by Terminix Global Holdings Inc. and Service Master Opco Holdings LLC. Employees will move to Peabody Place over several months and return to the St. Jude campus upon completion of the campus construction..
“Managing the logistics of widescale expansion plans, while ensuring day-to-day functions are uninterrupted, takes significant coordination,” said James R. Downing, M.D., St. Jude president and CEO. “The Peabody Place offices give us space to continue administrative operations while pursuing construction projects that support best-in-class environments for St. Jude patients, their families and our workforce.”
The six-year, $11.5 billion St. Jude strategic plan provides for $1.9 billion in new construction, renovation and capital needs. It also supports 1,400 additional jobs across scientific, clinical, administrative and global operations, as well as a modest increase to the number of new cancer patients accepted for treatment at the Memphis campus.
Planned growth includes the completion of the Domino’s Village, a 140-unit housing facility for patients and their families; construction of an outpatient facility and a clinical office building; and build-outs of two shelled floors in the recently opened 625,000-square-foot Inspiration4 Advanced Research Center.
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer, sickle cell disease, and other life-threatening disorders. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20% to 80% since the hospital opened more than 60 years ago. St. Jude shares the breakthroughs it makes to help doctors and researchers at local hospitals and cancer centers around the world improve the quality of treatment and care for even more children. To learn more, visit stjude.org, read St. Jude Progress, a digital magazine, and follow St. Jude on social media at @stjuderesearch.